It has been shown that blocking autocrine and paracrine IL-4 signalling impairs breast cancer stem-like cell proliferation, invasion, and tumor growth by downregulating MAPK pathway activity through up-regulation of DUSP4 [41]. This evidence concerns the gene DUSP4 and breast carcinoma.